PATIENT SAFETY

CDPH’s ASP promotes appropriate use of antimicrobials

The California Department of Public Health created the California Antimicrobial Stewardship Program (ASP) to educate healthcare facilities about the proper use of antibiotics and is developing statewide recommendations for ASPs. » More

CONTINUING EDUCATION

MTM and collaborative practice

Successful collaborative relationships with physicians and other healthcare providers greatly enhance patient care. Knowing how to build those relationships is job 1. Earn up to 2 CPE credits. » Click here to login and take the exams.

FDA ACTIONS

FDA investigating death following first dose of MS drug

FDA announced that it is evaluating the case of a patient with multiple sclerosis who died 24 hours following administration of the first dose of fingolimod (Gilenya). » More

FDA modifies REMS for 2 platelet-booster drugs

FDA announced changes to the Risk Evaluation and Mitigation Strategies for both Nplate (romiplostim) and Promacta (eltrombopag). » More

CLINICAL NEWS

Strict glycemic control may not help kidney patients

Both tight glycemic control and poor glycemic control are associated with worse outcomes in diabetics with chronic kidney disease, according to a new report in the Archives of Internal Medicine. » More

U.S. adopts much shorter TB treatment regimen

New U.S. guidelines on the treatment of latent tuberculosis slashes the amount of time needed to treat the infection from 9 months to 3. » More

FDA approves lower-dose topical oxybutynin gel 3% for overactive bladder

FDA has approved Antares' topical oxybutynin gel 3% product for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.
» More

Voices

•	Anticoagulation update
•	JP at Large
•	View from the Zoo
•	Viewpoints
•	Regulatory & Legal

Meetings & Events

Digital Edition

•	View current edition

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.